Cidara Therapeutics
CDTX
CDTX
108 hedge funds and large institutions have $1.26B invested in Cidara Therapeutics in 2025 Q2 according to their latest regulatory filings, with 70 funds opening new positions, 29 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
108
Holders Change
+62
Holders Change %
+134.78%
% of All Funds
1.45%
Holding in Top 10
9
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+200%
% of All Funds
0.12%
New
70
Increased
29
Reduced
6
Closed
8
Calls
$38M
Puts
$90.5M
Net Calls
-$52.4M
Net Calls Change
-$52.5M
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$111M |
| 2 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$87.6M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$68.9M |
| 4 |
CC
Commodore Capital
New York
|
+$57.2M |
| 5 |
BlackRock
New York
|
+$51.4M |
Top Sellers
| 1 |
VA
VR Adviser
New York
|
-$20.1M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$14M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$6.73M |
| 4 |
CC
Checkpoint Capital
San Francisco,
California
|
-$2.25M |
| 5 |
Goldman Sachs
New York
|
-$1.82M |
